PKU HealthCare Corp.,Ltd. (SHE:000788)
5.38
-0.12 (-2.18%)
Nov 13, 2026, 3:04 PM CST
PKU HealthCare Corp.,Ltd. Revenue
PKU HealthCare Corp.,Ltd. had revenue of 205.31M CNY in the quarter ending September 30, 2026, a decrease of -25.04%. This brings the company's total for the last twelve months to 903.60M, down -48.57% year-over-year. In the year 2025, PKU HealthCare Corp.,Ltd. had annual revenue of 1.48B, down -28.04%. That makes PKU HealthCare Corp.,Ltd. the 20,409th largest company in the world by revenue and 3,755th in China.
Revenue (ttm)
903.60M
Revenue Growth
-48.57%
P/S Ratio
3.63
Revenue / Employee
1.15M
Employees
789
Market Cap
3.21B
Revenue by Segment
- Sale of medicines, reagents, medical equipment 859.87M 58.0%
- Pharmaceutical Manufacturing 622.53M 42.0%
Fiscal year ended Dec 31, 2025 See the full PKU HealthCare Corp.,Ltd. breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.48B | -577.64M | -28.04% |
| Dec 31, 2024 | 2.06B | -133.78M | -6.10% |
| Dec 31, 2023 | 2.19B | 116.44M | 5.61% |
| Jan 1, 2023 | 2.08B | -159.42M | -7.13% |
| Jan 1, 2022 | 2.24B | 259.35M | 13.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Neptunus Bioengineering | 21.33B |
| Jinhe Biotechnology CO., LTD. | 2.94B |
| Huaren Pharmaceutical | 1.22B |
| ChengDu ShengNuo Biotec | 962.54M |
| Shaanxi Panlong Pharmaceutical Group | 917.38M |
| Harbin Medisan Pharmaceutical | 831.90M |
| Shandong Wohua Pharmaceutical | 781.18M |
| Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD | 710.26M |